Mendelian randomization studies support a causal role of remnant cholesterol in both inflammation and ischemic heart disease, highlighting that all ApoB-containing lipoproteins contribute similarly to ASCVD risk [53]. This evidence concerns the gene APOB and atherosclerosis.